Paratek Pharmaceuticals PRTK
$ 2.23
0.0%
Quarterly report 2023-Q2
added 08-03-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Evan Loh |
Employees in the company |
101 |
Shares |
54.4 M |
Market Cap[1] |
$ 121 M |
EBITDA (LTM) |
$ -58.6 M |
P/E (LTM) |
-1.73 |
P/S (LTM) |
0.99 |
EPS (LTM) |
-1.31 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.